Endurion is proud to announce a strategic partnership with leading global biotechnology companies aimed at advancing CAR-T therapy development.
Through this collaboration, Endurion will leverage combined expertise in cellular engineering, scalable manufacturing, and clinical development to accelerate the translation of CAR-T therapies from laboratory research to clinical application. This partnership strengthens Endurion’s commitment to delivering innovative, safe, and effective therapies to patients worldwide.
